RAND Health Care has been analyzing major issues related to public and private financing of health care since the program? inception in 1968. An early landmark study in this body of work is the RAND Health Insurance Experiment, still the largest health policy study in U.S. history. RAND work in this research area includes the organization and regulation of health care markets, the effects of population health on public financing, cost-effective allocation of private and public financing, and distributional issues in health and health care associated with health care financing, among others.
This population-based cross-sectional study found that although quality of care and patient experience were slightly higher with higher-premium plans, quality varied widely within each premium category.
This study aimed to compare the costs incurred and saved from universal use of N95 respirators with surgical masks for operating room providers in the United States during the COVID-19 pandemic.
Adding community-to-clinic tailored navigation to a community-based colorectal cancer screening promotion program may be highly cost-effective.
Clinical guidelines for colorectal cancer (CRC) screening suggest use of either stool-based tests or colonoscopy. We conducted a cost-effectiveness analysis to compare 2 mailed outreach strategies to increase CRC screening.
We find that Medicare Advantage beneficiaries with chronic conditions respond to changes in copays, although these responses are small. Reductions in copays lead to reduced use of specialists, suggesting that lowering copays could be a way to reduce specialist care.
Aducanumab, a weight-dosed Alzheimer's drug, is available in two fixed-dose vial sizes. This may result in large amounts of discarded drug and wasteful spending. More-efficient vial sizes could save Medicare money if the drug is approved for widespread use.
Testimony presented before the Texas House of Representatives Select Committee on Health Care Reform on August 4, 2022.
Microsimulation (Future Adult Model) predicted 30-year improved diet quality impacts across 12 demographic groups. Diet improvement reduced prevalence of heart disease by 7.6% to 13.8% across groups and reduced healthcare costs by $10B in year 30.
This report describes the reach and scope of Medicare's Part D Senior Savings model, which has lower, fixed cost sharing for a specified set of model drugs.
We conducted semi-structured interviews with 25 men who have sex with men who presented for routine health care at a STD clinic about their experiences with accessing and paying for PrEP.
This study was a cross-sectional mixed-methods analysis of in-depth multimodal data from 31 POs affiliated with 22 purposefully selected health systems in 4 states. Data were analyzed from June 2019 to September 2020.
This paper investigates adoption of behavioral nudges by health system-affiliated physician organizations (POs), types of nudges being used, PO leader perceptions of nudge effectiveness, and implementation challenges.
Because employer-sponsored spending comes from employee wages and benefits, employers have a fiduciary responsibility to administer benefits in the interest of participants. The lack of transparency of prices in the health care market limits the ability of employers to knowledgeably develop or implement benefit design decisions. This report is designed to allow an easy comparison of hospital prices using a single metric.
An estimated 3 million people currently insured in the individual market would lose coverage and become uninsured if the American Rescue Plan's premium tax credit provisions are not extended beyond 2022.
Biosimilar drugs could drive down prices for expensive medicines, with savings estimated at $38.4 billion from 2021 to 2022.
We describe how commercial hospital payment rates changed relative to Medicare rates during 2012–19 and how trends differed by hospital referral region.
The findings suggest that the out-of-pocket cost of naloxone has been an increasingly substantial barrier to naloxone access for uninsured patients, a population that constitutes nearly one-fifth of adults with opioid use disorder.
Most adults in this survey study were willing to use video visits for nonemergency care but preferred in-person care, suggesting that patient preferences will help define telehealth's role in US health care after the COVID-19 pandemic.
The 10Plan is a self-pay plan for individuals currently uninsured or covered by a private nongroup health insurance plan. The authors built a microsimulation model to estimate health care spending under both the status quo and the 10Plan.
The 10Plan is a self-pay plan for individuals currently uninsured or covered by a private nongroup health insurance plan. Individuals would pay no premiums up front, face Medicare rates, pay a copayment for each encounter, and have the option to pay cash for services or borrow from the government at a low interest rate to pay for care. The authors built a microsimulation model to estimate health care spending under the status quo and the 10Plan.
